Predictors of Response to Iron and Erythropoietin Stimulating Agents
- Conditions
- Renal Failure ChronicAnemia
- Interventions
- Registration Number
- NCT03658876
- Lead Sponsor
- Imperial College London
- Brief Summary
The purpose of the study is to identify predictors of treatment response. This involves collected baseline clinical parameters and bloods for biochemical parameters prior to administering the study treatment. A positive outcome following treatment was defined as an uptitration of haemoglobin by greater than 5g/l within 2 months. The study evaluated the participants response to treatment against the clinical and biochemical information collected prior to treatment being received.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 197
- All prevalent haemodialysis patients, established for greater than 3 months
Inability to consent Bone marrow disorder Transfusion dependence Active bleeding Active infection Active malignancy Frail with either frequent hospital admissions or unable to follow trial protocol due to differing target haemoglobin
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Iron group Iron Sucrose Solution for Injection - EPO group Epoetin Beta -
- Primary Outcome Measures
Name Time Method Hemoglobin Incrementation Within 2 months Incrementation of haemoglobin of 5g/l following treatment
- Secondary Outcome Measures
Name Time Method